From Name:
From Email:
To Name:
To Email:

Optional Message:


Everolimus plus letrozole effective in recurrent endometrial carcinoma

from Healio — HemOnc Today

The combination of everolimus and letrozole yielded high rates of objective response and clinical benefit in patients with recurrent endometrial carcinoma, according to results of a phase 2 study published in the Journal of Clinical Oncology. In prior studies, hormonal therapy and single-agent treatment with mTOR inhibitors such as everolimus have demonstrated effectiveness in women with metastatic or recurrent endometrial carcinoma. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063